TrialCancer communications (London, England)2025

A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort.

Young Kwang Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.